1
|
Salem H, Abdelaziz A, Galal M, Hussien M, Emad N, Batekh AE, Karem M, Moukhtar DA. Synchronous fluorescence as a green and selective method for the simultaneous determination of finasteride and tadalafil in dosage form and spiked human plasma. Spectrochim Acta A Mol Biomol Spectrosc 2023; 299:122838. [PMID: 37187147 DOI: 10.1016/j.saa.2023.122838] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/06/2023] [Revised: 05/04/2023] [Accepted: 05/05/2023] [Indexed: 05/17/2023]
Abstract
Finasteride and tadalafil are combined in a pharmaceutical capsules called Entadfi™, that has received FAD approval. It was indicated for the management of male benign prostatic hyperplasia-related urinary tract issues. In the current study, finasteride and tadalafil concentrations in raw form, laboratory prepared mixtures, pharmaceutical preparation and spiked human plasma were all quantitatively estimated using a sensitive synchronized fluorescence spectroscopic approach united with first derivative. When excited at 260 nm, finasteride display its emission at 320 nm. Yet, when excited at 280 nm, tadalafil displayed its emission at 340 nm. The application of micellar surfactant as sodium dodecyl sulphate (SDS) significantly increased the fluorescence intensity.The overlapping of the fluorescence spectra was entirely eliminated by derivatizing the synchronous spectra to the first derivative, which also made it possible to simultaneously quantify the cited drugs. Without interfering with one another, the first-order synchronous spectra of tadalafil and finasteride at 320 and 330 nm, respectively. The approach revealed linearity alongside an acceptable correlation coefficient for finasteride and tadalafil concentrations over the range of 10 -50 ng/mL. That approach was utilized to estimation of the cited drugs in dosage forms, simultaneously with %recoveries for tadalafil and finasteride of 99.62 ± 0.78 and 100.19 ± 0.60, respectively. Also, four various tools, the national environmental method index, the AGREE evaluation method, the green analytical procedure index and the analytical eco-scale were used to evaluate how environmentally friendly the given approach was. With regard to the metrics of the greenness aspects, the proposed approach appeared to be better than the previously published spectrophotometric methods and HPLC.
Collapse
Affiliation(s)
- Hesham Salem
- Pharmaceutical Chemistry Department, Faculty of Pharmacy, Deraya University, New Minia, Egypt.
| | - Amany Abdelaziz
- Pharmaceutical Chemistry Department, Faculty of Pharmacy, Deraya University, New Minia, Egypt
| | - Mariam Galal
- Faculty of Pharmacy, Deraya University, New Minia, Egypt
| | - Maha Hussien
- Faculty of Pharmacy, Deraya University, New Minia, Egypt
| | - Nadeen Emad
- Faculty of Pharmacy, Deraya University, New Minia, Egypt
| | - Asmaa E Batekh
- Faculty of Pharmacy, Deraya University, New Minia, Egypt
| | - Mohamed Karem
- Faculty of Pharmacy, Deraya University, New Minia, Egypt
| | - Deena A Moukhtar
- Analytical Chemistry Department, Faculty of Pharmacy, Minia University, Minia, Egypt
| |
Collapse
|
2
|
Salem H, Mazen DZ, Emad N, Hassan H, Omran B, Abdelmajed MA. Green micellar spectrofluorimetric determination of α-mangostin as antioxidant and other biological activities beneficial to human health found in herbal products. LUMINESCENCE 2023. [PMID: 37078125 DOI: 10.1002/bio.4509] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/04/2023] [Revised: 03/06/2023] [Accepted: 03/09/2023] [Indexed: 04/21/2023]
Abstract
Pharmaceutical product quality control (QC) needs for quick, sensitive, and economical procedures in order to deliver high throughput at low cost, which is the key factor taken into account by such economic facilities. To lessen the risky effects of research laboratories, researchers must take into account the ecological impacts. Anti-inflammatory, antioxidant, anticancer, anti-allergic, antibacterial, antifungal, antiviral, and antimalarial activities are all possessed by α-mangostin (MAG). Based on spectrofluorimetric approach, a novel straightforward, sensitive, and environmentally friendly method for MAG determination was developed and validated. Numerous variables were investigated to enhance MAG native fluorescence, including solvent type, buffering, pH, and additional surfactants. The best MAG fluorescence sensitivity was found in Britton-Robinson buffer (pH 4) at 450 nm following irradiation at 350 nm in the concentration range of 5-50 ng mL-1. The technique was successfully used to determine the presence of MAG in both its approved dose forms and in samples of spiked human plasma, as per FDA standards for validation. According to their evaluation on two recent greenness criteria (GAPI and AGREE), the suggested approach has been shown to be environmentally beneficial because it normally uses bio degradable chemicals in solvent-free aqueous phases.
Collapse
Affiliation(s)
- Hesham Salem
- Pharmaceutical chemistry department, faculty of pharmacy, Deraya University, New Minia, Egypt
| | - Dina Z Mazen
- Pharmaceutical chemistry department, faculty of pharmacy, Deraya University, New Minia, Egypt
| | - Nadeen Emad
- Pharmaceutical chemistry department, faculty of pharmacy, Deraya University, New Minia, Egypt
| | - Hossam Hassan
- Pharmaceutical chemistry department, faculty of pharmacy, Deraya University, New Minia, Egypt
| | - Bahaa Omran
- Pharmaceutical chemistry department, faculty of pharmacy, Deraya University, New Minia, Egypt
| | - Mahmoud A Abdelmajed
- Pharmaceutical chemistry department, faculty of pharmacy, Deraya University, New Minia, Egypt
| |
Collapse
|
3
|
AbdelMassih A, Gadalla M, Hussein E, Elahmady M, Zahra N, Eid MA, Hussein M, Hassan AA, Abou-Zeid AS, Hassan A, El Nahhas N, Emad N, Aboushadi N, Ibrahim N, Mokhtar S, El-Husseiny N, Kamel A, Hozaien R, Menshawey E, Ismail HA, Mokhles M, Menshawey R, Fouda R. The forgotten oral microbial transplantation for improving the outcomes of COVID-19. New Microbes New Infect 2021; 43:100923. [PMID: 34336224 PMCID: PMC8310390 DOI: 10.1016/j.nmni.2021.100923] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/23/2021] [Revised: 06/17/2021] [Accepted: 07/19/2021] [Indexed: 12/31/2022] Open
Abstract
Ever since the uncovering of the severe discrepancy of COVID-19 manifestations, irrespective of viral load, scientists have raced to locate and manage factors contributing to the genesis of a critical state. Recent evidence delineates the role of oral dysbiosis in the development of low-grade inflammation, characterized by the increase of inflammatory cytokines common to those fundamental to the development of severe COVID. Furthermore, high periodontopathic bacteria were recorded in severe acute respiratory syndrome in COVID patients, as well as its common provoking comorbidities such as diabetes and hypertension. This can be explained by the immigration and elimination of oral bacteria into the airways, which, in the context of an injured lung, allows for their preferential overgrowth familiar to that, causing the progression to advanced lung diseases. This is why we indicate the promising usage of oral microbiome transplantation as a treatment of oral microbial dysbiosis, not only associated with the worst outcomes of COVID-19 but also in other disorders of low-grade inflammation.
Collapse
Affiliation(s)
- A AbdelMassih
- Pediatric Cardiology Unit, Pediatrics' Department, Faculty of Medicine, Cairo University, Egypt.,Pediatric Cardio-Oncology Department, Children Cancer Hospital of Egypt (57357), Egypt
| | - M Gadalla
- Faculty of Dentistry, New Giza University, New Giza, Egypt.,Research Accessibility Team (Students' and Interns' Research Program), Faculty of Medicine, Cairo University, Egypt
| | - E Hussein
- Faculty of Dentistry, New Giza University, New Giza, Egypt.,Research Accessibility Team (Students' and Interns' Research Program), Faculty of Medicine, Cairo University, Egypt
| | - M Elahmady
- Faculty of Dentistry, New Giza University, New Giza, Egypt.,Research Accessibility Team (Students' and Interns' Research Program), Faculty of Medicine, Cairo University, Egypt
| | - N Zahra
- Faculty of Dentistry, New Giza University, New Giza, Egypt.,Research Accessibility Team (Students' and Interns' Research Program), Faculty of Medicine, Cairo University, Egypt
| | - M A Eid
- Faculty of Dentistry, New Giza University, New Giza, Egypt.,Research Accessibility Team (Students' and Interns' Research Program), Faculty of Medicine, Cairo University, Egypt
| | - M Hussein
- Faculty of Dentistry, New Giza University, New Giza, Egypt.,Research Accessibility Team (Students' and Interns' Research Program), Faculty of Medicine, Cairo University, Egypt
| | - A A Hassan
- Faculty of Dentistry, New Giza University, New Giza, Egypt.,Research Accessibility Team (Students' and Interns' Research Program), Faculty of Medicine, Cairo University, Egypt
| | - A S Abou-Zeid
- Faculty of Dentistry, New Giza University, New Giza, Egypt.,Research Accessibility Team (Students' and Interns' Research Program), Faculty of Medicine, Cairo University, Egypt
| | - A Hassan
- Faculty of Dentistry, New Giza University, New Giza, Egypt.,Research Accessibility Team (Students' and Interns' Research Program), Faculty of Medicine, Cairo University, Egypt
| | - N El Nahhas
- Faculty of Dentistry, New Giza University, New Giza, Egypt.,Research Accessibility Team (Students' and Interns' Research Program), Faculty of Medicine, Cairo University, Egypt
| | - N Emad
- Faculty of Dentistry, New Giza University, New Giza, Egypt.,Research Accessibility Team (Students' and Interns' Research Program), Faculty of Medicine, Cairo University, Egypt
| | - N Aboushadi
- Faculty of Dentistry, New Giza University, New Giza, Egypt.,Research Accessibility Team (Students' and Interns' Research Program), Faculty of Medicine, Cairo University, Egypt
| | - N Ibrahim
- Faculty of Dentistry, New Giza University, New Giza, Egypt.,Research Accessibility Team (Students' and Interns' Research Program), Faculty of Medicine, Cairo University, Egypt
| | - S Mokhtar
- Faculty of Dentistry, New Giza University, New Giza, Egypt.,Research Accessibility Team (Students' and Interns' Research Program), Faculty of Medicine, Cairo University, Egypt
| | - N El-Husseiny
- Research Accessibility Team (Students' and Interns' Research Program), Faculty of Medicine, Cairo University, Egypt.,Faculty of Dentistry, Cairo University, Egypt.,Pixagon Graphic Design Agency, Cairo, Egypt
| | - A Kamel
- Research Accessibility Team (Students' and Interns' Research Program), Faculty of Medicine, Cairo University, Egypt
| | - R Hozaien
- Research Accessibility Team (Students' and Interns' Research Program), Faculty of Medicine, Cairo University, Egypt
| | - E Menshawey
- Research Accessibility Team (Students' and Interns' Research Program), Faculty of Medicine, Cairo University, Egypt
| | - H A Ismail
- Research Accessibility Team (Students' and Interns' Research Program), Faculty of Medicine, Cairo University, Egypt
| | - M Mokhles
- Research Accessibility Team (Students' and Interns' Research Program), Faculty of Medicine, Cairo University, Egypt
| | - R Menshawey
- Research Accessibility Team (Students' and Interns' Research Program), Faculty of Medicine, Cairo University, Egypt
| | - R Fouda
- Clinical and Chemical Pathology Department, Faculty of Medicine, Cairo University, Egypt
| |
Collapse
|